3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
CNS
1
Conditions
Carcinoma, Non-Small-Cell Lung
184
Neoplasm Metastasis
149
Neoplasms
140
Leukemia, Myeloid, Acute
133
Colorectal Neoplasms
131
Breast Neoplasms
122
Melanoma
94
Ovarian Neoplasms
93
Recurrence
88
Prostatic Neoplasms
88
Multiple Myeloma
84
Pancreatic Neoplasms
76
Squamous Cell Carcinoma of Head and Neck
74
Lung Neoplasms
74
Glioblastoma
74
Lymphoma, Non-Hodgkin
67
Myelodysplastic Syndromes
62
Triple Negative Breast Neoplasms
58
Glioma
56
Precursor Cell Lymphoblastic Leukemia-Lymphoma
53
Stomach Neoplasms
52
Endometrial Neoplasms
50
Brain Neoplasms
48
Carcinoma, Renal Cell
47
Small Cell Lung Carcinoma
46
Lymphoma, Large B-Cell, Diffuse
46
Carcinoma, Hepatocellular
45
Lymphoma, Follicular
41
Lymphoma, B-Cell
41
Sarcoma
40
Interventions
fludarabine phosphate
1
fludarabine
1
Herpes Zoster Vaccine
1
Cyclophosphamide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1
×
Chickenpox
×
90 days
×
Clear all
NCT01953900
2026-04-22
VEGAS
Baylor College of Medicine
Phase 1
Active not recruiting
26 enrolled